Australia markets closed

Noxopharm Limited (NOX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0630+0.0030 (+5.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
-
-
-
-
7,333
Selling general and administrative
4,697
5,076
6,583
6,363
6,443
Total operating expenses
11,101
16,595
15,208
20,214
16,366
Operating income or loss
-11,101
-16,595
-15,208
-20,214
-16,366
Interest expense
59.885
40.995
77.335
2,186
3,467
Total other income/expenses net
-992.697
1,497
-3,429
12,914
18,822
Income before tax
-12,128
-15,056
-18,667
-9,347
-999.573
Income tax expense
0
0
0
0
0
Income from continuing operations
-12,128
-15,056
-18,667
-9,347
-999.573
Net income
-12,128
-15,056
-18,667
-9,347
-272.093
Net income available to common shareholders
-12,128
-15,056
-18,667
-9,347
-272.093
Basic EPS
-0.05
-0.05
-0.06
-0.04
-0.00
Diluted EPS
-0.05
-0.05
-0.06
-0.04
-0.00
Basic average shares
292,238
292,238
291,222
263,851
138,358
Diluted average shares
292,238
292,238
291,222
263,851
138,358